edoc

Browse by Basel Contributors ID

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2021 | 2020 | 2019 | 2018 | 2017

2021

Herbrand, Amanda Katherina and Schmitt, Andreas M. and Briel, Matthias and Ewald, Hannah and Goldkuhle, Marius and Diem, Stefan and Hoogkamer, Anouk and Joerger, Markus and Moffa, Giusi and Novak, Urban and Hemkens, Lars G. and Kasenda, Benjamin. (2021) Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs. Jama Network Open, 4 (3). e210380.

2020

Speich, Benjamin and Gloy, Viktoria and Schur, Nadine and Ewald, Hannah and Hemkens, Lars G. and Schwenkglenks, Matthias and Briel, Matthias and MAking Randomized Trials Affordable Group, . (2020) A scoping review shows that several nonvalidated budget planning tools for randomized trials are available. Journal of Clinical Epidemiology, 117. pp. 9-19.

Janiaud, Perrine and Axfors, Cathrine and Van't Hooft, Janneke and Saccilotto, Ramon and Agarwal, Arnav and Appenzeller-Herzog, Christian and Contopoulos-Ioannidis, Despina G. and Danchev, Valentin and Dirnagl, Ulrich and Ewald, Hannah and Gartlehner, Gerald and Goodman, Steven N. and Haber, Noah A. and Ioannidis, Angeliki Diotima and Ioannidis, John P. A. and Lythgoe, Mark P. and Ma, Wenyan and Macleod, Malcolm and Malički, Mario and Meerpohl, Joerg J. and Min, Yan and Moher, David and Nagavci, Blin and Naudet, Florian and Pauli-Magnus, Christiane and O'Sullivan, Jack W. and Riedel, Nico and Roth, Jan A. and Sauermann, Mandy and Schandelmaier, Stefan and Schmitt, Andreas M. and Speich, Benjamin and Williamson, Paula R. and Hemkens, Lars G.. (2020) The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days. F1000Research, 9. p. 1193.

Ladanie, Aviv and Schmitt, Andreas M. and Speich, Benjamin and Naudet, Florian and Agarwal, Arnav and Pereira, Tiago V. and Sclafani, Francesco and Herbrand, Amanda K. and Briel, Matthias and Martin-Liberal, Juan and Schmid, Thomas and Ewald, Hannah and Ioannidis, John P. A. and Bucher, Heiner C. and Kasenda, Benjamin and Hemkens, Lars G.. (2020) Clinical trial evidence supporting US Food and Drug Administration approval of novel cancer therapies between 2000 and 2016. Jama Network Open, 3 (11). e2024406.

2019

Speich, Benjamin and Schur, Nadine and Gryaznov, Dmitry and von Niederhäusern, Belinda and Hemkens, Lars G. and Schandelmaier, Stefan and Amstutz, Alain and Kasenda, Benjamin and Pauli-Magnus, Christiane and Ojeda-Ruiz, Elena and Tomonaga, Yuki and McCord, Kimberly and Nordmann, Alain and von Elm, Erik and Briel, Matthias and Schwenkglenks, Matthias and a collaboration of the Marta Aspire Study Groups, . (2019) Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation. PLoS ONE, 14 (1). e0210669.

Ewald, Hannah and Ioannidis, John P. A. and Ladanie, Aviv and Mc Cord, Kimberly and Bucher, Heiner C. and Hemkens, Lars G.. (2019) Nonrandomized studies using causal-modeling may give different answers than RCTs: a meta-epidemiological study. Journal of clinical epidemiology, 118. pp. 29-41.

2018

Speich, Benjamin and von Niederhäusern, Belinda and Blum, Claudine Angela and Keiser, Jennifer and Schur, Nadine and Fürst, Thomas and Kasenda, Benjamin and Christ-Crain, Mirjam and Hemkens, Lars G. and Pauli-Magnus, Christiane and Schwenkglenks, Matthias and Briel, Matthias and Making Randomized Trials Affordable Group, . (2018) Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list. Journal of clinical epidemiology, 96. pp. 73-83.

Speich, Benjamin and von Niederhäusern, Belinda and Schur, Nadine and Hemkens, Lars G. and Fürst, Thomas and Bhatnagar, Neera and Alturki, Reem and Agarwal, Arnav and Kasenda, Benjamin and Pauli-Magnus, Christiane and Schwenkglenks, Matthias and Briel, Matthias and Making Randomized Trials Affordable Group, . (2018) Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data. Journal of clinical epidemiology, 96. pp. 1-11.

2017

Schandelmaier, Stefan and Tomonaga, Yuki and Bassler, Dirk and Meerpohl, Joerg J. and von Elm, Erik and You, John J. and Bluemle, Anette and Lamontagne, Francois and Saccilotto, Ramon and Amstutz, Alain and Bengough, Theresa and Stegert, Mihaela and Olu, Kelechi K. and Tikkinen, Kari A. O. and Neumann, Ignacio and Carrasco-Labra, Alonso and Faulhaber, Markus and Mulla, Sohail M. and Mertz, Dominik and Akl, Elie A. and Sun, Xin and Busse, Jason W. and Ferreira-González, Ignacio and Nordmann, Alain and Gloy, Viktoria and Raatz, Heike and Moja, Lorenzo and Rosenthal, Rachel and Ebrahim, Shanil and Vandvik, Per O. and Johnston, Bradley C. and Walter, Martin A. and Burnand, Bernard and Schwenkglenks, Matthias and Hemkens, Lars G. and Guyatt, Gordon and Bucher, Heiner C. and Kasenda, Benjamin and Briel, Matthias. (2017) Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort Study. The Journal of Pediatrics, 184. pp. 209-214.e1.